Articles On Apiam Animal Health (ASX:AHX)

ASX healthcare stocks underperform but optimism grows Uscom, Respiri and Hitiq report mixed results Artrya and Nyrada make key clinical advances   The S&P/ASX 200 Health Care [XHJ] index was down 0.9% gain in October. For the year, th...

Bendigo-based vet services business Apiam Animal Health (ASX: AHX) has been flagged as a potential takeover target in a sector that has rarely been out of the spotlight over the past five years following a series of big-ticket buyouts. Api...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Equities overnight had another positive session, both in the US and in Europe, and t...

Healthcare stocks are doing relatively well globally in 2024
 The sector could see more recovery as Fed cuts rates
 How ASX biotechs performed in the month of September   The S&P 500 Health Care Index, a key world benchmark for health...

  On Friday, the Dow Jones Industrial Average hit a new record high as traders processed fresh data indicating ongoing progress in curbing inflation. Wall Street also celebrated its third consecutive week of gains. The 30-stock Dow increase...

On Friday, the Dow Jones Industrial Average hit a new record high as traders processed fresh data indicating ongoing progress in curbing inflation. Wall Street also celebrated its third consecutive week of gains. The 30-stock Dow increased...

Birth rates decline as people choose careers and pets Global pet industry is benefitting from this, to grow significantly by 2030 Ethical investing could thrive in sustainable pet product demand   The conversation around motherhood is evo...

ASX health stocks down in August and trail the broader market in 2024 CSL up 6,000pc since listing; sector outpaced benchmark 10x since 2006 AI is revolutionising healthcare, boosting diagnosis and treatment   The ASX Healthcare Index (AS...

  US stocks closed slightly higher on Tuesday as investors looked ahead to a crucial earnings report from Nvidia. The broad-based S&P 500 gained 0.16 per cent to finish at 5,625.80, while the tech-heavy Nasdaq Composite rose 0.16 per ce...

S&P/ASX 200 Health Care index up 5pc in July, 9.5pc YTD Health sector gains momentum with expected Fed rate cuts; ResMed seen as a strong buy And ASX healthcare winners and losers in July   The S&P/ASX 200 Health Care index [XHJ]...

The EMA has rejected the Alzheimer’s drug Leqembi, developed by Eisai and Biogen There is one ASX-listed company that collaborates with Eisai We take a look at the best performing ASX health stocks in the past month   In a major blow for...

The ASX Health Care index saw a 4% increase in June Growth was driven by CSL and Cochlear Best biotechs in June were Actinogen, Optiscan and EZZ Life Science, amongst others    The S&P/ASX 200 Health Care index [XHJ] saw a 4% increase...

 S&P/ASX 200 Health Care closed flat in May 2024 brings challenges, but hopes are high for biotech stocks We take a look at the ASX biotech winners for the month   The  S&P/ASX 200 Health Care [XHJ] closed flattish for the month o...

Research shows Alzheimer’s is entirely preventable A poor diet and bad gut bacteria can increase the risk of dementia We look at the best performing ASX stocks over the past month    The phrase ‘you are what you eat’ was coined almost a c...

ASX Health sector was in correction territory in April Why is the health sector different from other sectors? We look at the best performing ASX health stocks for the month   The S&P/ASX 200 Health Care [XHJ] had a soft month in April...

There’s been a breakthrough in acne treatment Scientists have found a way to use skin bacteria to control sebum production We look at the best and worst performing ASX health stocks in the past month   Scientists have made a significant b...

ASX Health Index down -1.5% for February 76 biotechs rose, and 78 fell during the month But essentially, biotech is a long term game for investors   The S&P/ASX 200 Health Care [XHJ] struggled in February, finishing -1.5% lower and tr...

Viking Therapeutics doubled after results of weight loss drug trial Janux Therapeutics tripled on pancreatic cancer results We look at the recent best performing ASX health stocks   There were a couple of big news from the world of biotec...

  Local markets end Friday (and the week) ahead circa 0.4pc IT sector booms 1.5pc Small caps led by WhiteHawk   The ASX200 has kept its head and ended Friday higher thanks to a boost from local tech stocks. At 4.15pm on Friday February 23...

Apiam surged as high as +27pc this morning Cleanspace had a strong first half AVITA Medical’s Q4 revenue also climbed higher   Apiam Health jumps much higher after strong H1 Rural veterinary business, Apiam Animal Health (ASX:AHX), jumped...

Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help...

The ASX benchmark has ended Tuesday higher 8 of 11 sectors in the green Small caps led by Plenti Group (ASX:PLT), InteliCare (ASX:ICR) The local market has trimmed some of its early gains (wussed out) after jumping out of the blocks in...

Benchmark ASX index finishes ever so slightly up ASX Sectors led by Financial, IT, Property and Materials Small cap gainers: RBL, PIL, and LPI   Here’s how we ended on Thursday. Local markets largely did okay, and then wilted when we go...

Stockhead’s In-Case-You-Missed-It highlights today’s most interesting small cap stories that might have slipped beneath your radar. Below is a wrap of the top 20 performing stocks, by percentage, who made announcements today.   ICYMI Leader...

Let's talk about the unbreakable bond between households and their pets, and about the companies that offer exposure -Demand for premium goods and services for pets is strong and resilient-Australia has one of the highest pet ownership rate...

Small cap health stocks are not known to pay dividends But there’s a handful of such stocks on the ASX that do pay dividends We look at the best and worst performing ASX biotechs over the past week   When we talk about dividend-paying hea...

Humanisation of pets trend continues to benefit ASX pet stocks Apiam Animal Health reports ~25% increase in revenue as pet owners seek higher standards of care Mad Paws on track for operating EBITDA break even target by mid-2023 as profit...

Rural veterinary clinic aggregator Apiam Animal Health (ASX: AHX) has corralled five new clinics in high-growth regional areas of NSW through two separate acquisitions worth $11.2 million. The buyouts more than double the mixed animal clin...

ShareCafeRetail investors switching to cash: Tesla under pressure                    Stocks fell in choppy trading on Thursday as investors weighed several key earnings reports and kept an eye on the bond market, where Treasury yields...

Apiam Animal Health (AHX) acquires veterinary business Harradine & Associates for $2.6 millionUnder the deal, Apium will pay for the acquisition in 80 per cent cash and 20 per cent scripApiam says that located in Bunbury, Western Austra...

Cynata gets green light for clinical trial from an independent review Apiam acquires large vet business in WA Cynata Therapeutics (ASX:CYP) shares surged 6% after the company announced that an independent review of its diabetic foot ulcer...

ShareCafeMetaverse stocks struggling, as bond yields head towards 4%                    Stocks were lower on Tuesday as investors braced for another large rate hike due out Wednesday from the Federal Reserve. The Dow Jones Industrial...

An additional news report on the recommendation, valuation, forecast and opinion changes for ASX-listed equities. In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now added The Au...

An additional news report on the recommendation, valuation, forecast and opinion changes for ASX-listed equities. In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now added The Au...

Biome Australia to release more than 47 million shares as Priceline deals sees share price lift Minerals explorer Ballymore Resources to release more than 2 million shares from voluntary escrow Chemical company DGL Group to release more th...

Apiam Animal Health (AHX) launches an entitlement offer to raise up to $20.25 million for its accelerated acquisition strategy and debt repayment Eligible shareholders will be able to subscribe for one new shares for every 4.8 held at a pr...

Both ASX Small Cap and benchmark index are down about 0.5% A bleak forecast from Covid-stricken China hits resources stocks Appen in trading halt after jumping 30%     Local markets took a turn for the worse on Thursday after Chinese Prem...

Shaw and Partners is pleased to be appointed as Joint Lead Manager to the proposed capital raising by Apiam Animal Health Limited (ASX.AHX)   The company is proposing to ... Read More

Gold explorer Predictive Discovery and veterinary business Apiam Animal Health were out fronting investors with cash calls on Thursday. 

Highlights Acquisitions have proven to be a great way for business expansion AHX has implemented binding agreements to acquire the assets of Victorian Equine Group and Romsey Veterinary Surgery Ramsay recently completed 100% acquisiti...

Apiam Animal Health (AHX) is acquiring two veterinary businesses for a combined cash and scrip consideration of $13.75 million The first is Victorian Equine, which provides various services for horses and will add a third cornerstone equin...

Little Green Pharma expands footprints in Germany after signing a large supply deal Apiam Health acquires two vet networks Cannabis company Little Green Pharma (ASX:LGP) has signed a large-volume, take-or-pay contract with Four 20 Pharma...

Vet services business Apiam Animal Health (ASX: AHX) has gone from a canter to a trot with its aggressive acquisition strategy aimed at doubling revenues to $300 million within two years, announcing agreements to purchase Victorian Equine G...

Apiam Animal Health (AHX) receives a $700,000 grant to build a new viral vaccine laboratory in Bendigo from the Victorian State Government’s Regional Jobs Fund It will enable the company to fast track development of the lab and fill a need...

Highlights 5 ASX-listed companies Adairs Limited (ASX:ADH), Apiam Animal Health Ltd (ASX:AHX), K&S Corporation Limited (ASX:KSC), NRW Holdings Limited (NWH), and Paragon Care Ltd (ASX:PGC), turned ex-dividend today.    The share...

Australia’s largest regional veterinary network continues its expansion with the purchase of two key acquisitions. Animal health company Apiam (ASX:AHX) has purchased two key veterinary businesses in New South Wales and Queensland for a co...

Wall Street mainly up as jobless claims hit five-decade low US stocks mainly rose on Wednesday as US jobless claims hit the lowest level since 1969. Americans claiming for unemployment welfare were 190,000 for the week, way below the estima...

The Agnes Bank clinic in NSW will help cornerstone Apiam’s broader strategic push into equine services in regional markets. For leading veterinary and animal health practice Apiam (ASX:AHX), 2021 has been a transformational year for its str...

The ASX 200 Health Index (XHJ) is up by 0.80% at the time of writing, compared to the broader index which is up by 0.30%. Immutep Limited (ASX:IMM) has has successfully completed patient recruitment for the Phase II TACTI-002 study of LAG-3...

The increasing adoption and personification of pets presents several opportunities for ASX investors, and one of these is in the pet nutrition space. IBIS World estimates the total pet market is $13 billion and pet nutrition accounts for $2...